Author:
Cummings Jeffrey,Meikle Ian,Macpherson Janet S.,Smyth John F.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference32 articles.
1. Anderson L, Cummings J, Bradsshaw T, Smyth JF (1991) The role of protein kinase C and the phosphatidylinositol cycle in multidrug resistance in human ovarian cancer cells. Biochem Pharmacol 42: 1427
2. Beck WT (1989) Unknotting the complexities of multidrug resistance: the involvement of DNA topisomerases in drug action and resistance. J Natl Cancer Inst 81: 1683
3. Beck WT, Kim R, Chen M (1994) Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumour cells. Cancer Chemother Pharmacol 34 [Suppl]: S14
4. Boritzki TJ, Wolfard TS, Besserer JA, Jackson RC, Fry DW (1988) Inhibition of type II topoisomerase by fostriecin. Biochem Pharmacol 37: 4603
5. Burke TG, Morin MJ, Sartorelli AC, Lane PE, Tritton TR (1987) Function of the anthracycline amino group in cellular transport and cytotoxicity. Mol Pharmacol 31: 552
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献